Cellmid 2018 Annual Report
Interest rate risk
The Group’s main interest rate risk arises from loans from banks and other financial institutions.
The Group has performed a sensitivity analysis relating to its exposure to interest rate risk at the end of the financial year. The
sensitivity analysis demonstrates the effect on the current year results and equity which could result from a change in this risk.
At the end of the financial year, the effect on loss and equity as a result of changes in the interest rate with all other variables
remaining constant would be as follows:
The consolidated financial statements incorporate the assets, liabilities and results of the following wholly-owned subsidiaries
in accordance with the accounting policy described in Note 1:
Loss Equity
$ $
Year ended 30 June 2018
+/- 1% in interest rates +/- 31,739 +/- 31,739
Year ended 30 June 2017
+/- 1% in interest rates +/- 39,946 +/- 39,946
Name Country of Percentage Owned (%) Percentage Owned (%)
Incorporation 2018 2017
Subsidiaries of Cellmid Limited:
Advangen Limited Australia 100 100
Kinera Limited Australia 100 100
Lyramid Limited Australia 100 100
Subsidiaries of Advangen Limited:
Advangen International Pty Ltd Australia 100 100
Advangen Incorporated Japan 100 100
Advangen LLC USA 100 100
Guarantees entered into by the parent entity in relation to the debts of its subsidiaries
On 30 June 2016, Cellmid Limited entered into a deed of cross guarantee to support the liabilities and obligations of four
of its wholly-owned subsidiaries, Advangen Limited, Kinera Limited, Lyramid Limited and Advangen International Pty Ltd. By
entering into the deed, the wholly-owned unlisted public entities have been relieved from the requirement to prepare a financial
report and directors’ report under ASIC Corporations (wholly-owned companies) Instrument 2016/785 issued by the Australian
Securities and Investments Commission.